2 No-Brainer Healthcare Stocks to Buy Now
Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…
Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks
A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company…
How Recent Moves Are Rewriting the Story for Pfizer
Pfizer’s fair value estimate has inched upward recently, rising from $28.86 to $29.08 per share. The discount rate…
Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
One of the most compelling acquisition sagas in the pharma industry in recent times has come to an…
Why Weight-Loss Drug Prices Are Falling| Business News
President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
Trump seeks lower prices for Wegovy, Zepbound
President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
Bank of Ireland revises its forecast for the economy upwards with strong export growth
Bank predicts GDP will grow by 10.7pc this year as Ireland weathers tariffs storm well Bank of Ireland…
Despite global headwinds, the Irish economy is projected to grow by almost 11% – The Irish Times
Bank of Ireland has upgraded its forecast for Irish economic growth this year to almost 11 per cent,…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
Here Are 2 With Even More Upside Ahead
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to…